Rare Autoimmune Diseases Affecting the Lungs: Symptoms & Treatment

Rare autoimmune diseases affecting the lungs occur when the immune system mistakenly attacks healthy lung tissue. This immune response can trigger inflammation, lung scarring (fibrosis), and breathing difficulties. Many of these disorders are systemic, meaning they may also affect joints, blood vessels, skin, kidneys, or other organs.

Although these conditions are uncommon, early diagnosis and proper treatment can help slow disease progression and improve quality of life.

Common Symptoms

Symptoms often develop gradually and may resemble other respiratory illnesses. Common warning signs include:

Persistent dry cough
Shortness of breath, especially during physical activity
Fatigue and muscle weakness
Chest discomfort or chest pain
Unexplained weight loss or fever
Wheezing or breathing difficulty
Clubbing of the fingers in advanced disease stages

Because symptoms can overlap with asthma, COPD, or infections, specialized testing is often necessary for an accurate diagnosis.

Major Types of Autoimmune Lung Diseases

Several rare autoimmune disorders can directly affect the lungs.

1. Interstitial Lung Disease (ILD)

Interstitial Lung Disease associated with autoimmune disorders causes inflammation and scarring in the lung tissue. It is commonly linked to connective tissue diseases such as:

Rheumatoid arthritis-associated ILD
Scleroderma-associated ILD
Polymyositis and dermatomyositis
Sjögren’s syndrome

Over time, ILD may lead to pulmonary fibrosis and reduced oxygen exchange.

2. Granulomatosis with Polyangiitis (GPA)

Granulomatosis with Polyangiitis is a rare form of vasculitis that inflames blood vessels and creates granulomas in the lungs, sinuses, and kidneys. Symptoms may include coughing, nasal congestion, fatigue, and coughing up blood.

3. Sarcoidosis

Sarcoidosis causes clusters of inflammatory cells called granulomas to develop in the lungs and lymph nodes. While some cases resolve naturally, others can become chronic and lead to lung damage.

4. Eosinophilic Granulomatosis with Polyangiitis (EGPA)

EGPA is a rare autoimmune condition involving asthma, elevated eosinophil levels, and inflammation of small blood vessels. Lung involvement is common and may cause severe respiratory symptoms.

5. Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Autoimmune Pulmonary Alveolar Proteinosis occurs when surfactant material accumulates inside the air sacs of the lungs, interfering with oxygen absorption and causing progressive breathing problems.

Diagnosing Autoimmune Lung Conditions

Diagnosing a rare autoimmune disease affecting the lungs typically requires collaboration between pulmonologists and rheumatologists.

Common diagnostic tools include:

High-Resolution CT (HRCT) Scan

HRCT imaging helps identify lung inflammation, fibrosis patterns, and structural damage.

Blood Tests

Bloodwork may detect autoimmune antibodies such as:

ANA (Antinuclear Antibodies)
ANCA (Antineutrophil Cytoplasmic Antibodies)
Rheumatoid factor (RF)
Anti-CCP antibodies

Pulmonary Function Tests (PFTs)

These tests measure lung capacity and oxygen exchange to evaluate breathing performance.

Lung Biopsy

In certain cases, a tissue biopsy may be needed to confirm the diagnosis and determine the exact disease type.

Treatment Options for Autoimmune Lung Diseases

Treatment focuses on controlling inflammation, slowing fibrosis, and preserving lung function.

Immunosuppressive Medications

Doctors commonly prescribe medications such as:

Corticosteroids (prednisone)
Mycophenolate mofetil
Azathioprine
Cyclophosphamide

These drugs help reduce immune system activity and inflammation.

Biologic Therapies

Biologic medications like rituximab may be used for autoimmune vasculitis and severe connective tissue diseases.

Antifibrotic Therapy

For progressive pulmonary fibrosis, antifibrotic drugs such as nintedanib and pirfenidone may help slow lung scarring.

Oxygen Therapy

Supplemental oxygen can improve breathing and support daily activity in advanced disease.

Pulmonary Rehabilitation

Structured rehabilitation programs help patients improve endurance, breathing techniques, and physical conditioning.

Lung Transplant

In severe end-stage lung disease, lung transplantation may be considered for eligible patients.

Understanding Pulmonary Fibrosis and Disease Progression

Many autoimmune lung diseases can lead to pulmonary fibrosis, a condition where scar tissue gradually stiffens the lungs.

Pulmonary Fibrosis Stages

Mild Stage

Minimal symptoms
Shortness of breath during exertion
Mild CT scan abnormalities

Moderate Stage

Increased breathing difficulty
Reduced lung function test results
Fatigue during daily activities

Severe Stage

Significant oxygen dependence
Major decline in lung capacity
Limited physical activity

Regular monitoring through imaging and pulmonary testing helps doctors track disease progression and adjust treatment plans.

Hypersensitivity Pneumonitis and Autoimmune Lung Disease

Some patients develop lung inflammation from repeated exposure to environmental triggers such as mold, bird proteins, or dust. This condition is called Hypersensitivity Pneumonitis (HP).

Hypersensitivity Pneumonitis Treatment

Treatment usually involves:

Identifying and avoiding environmental triggers
Corticosteroid therapy to reduce inflammation
Long-term immunosuppressive medication if fibrosis develops

Early antigen avoidance is one of the most important steps in preventing permanent lung damage.

Living with an Autoimmune Lung Disease

Managing a chronic autoimmune lung condition requires long-term medical care and lifestyle adjustments.

Infection Prevention

Because many treatments suppress the immune system, patients should stay current with vaccinations and practice good infection prevention habits.

Exercise and Rehabilitation

Pulmonary rehabilitation and light physical activity can help maintain stamina and respiratory strength.

Emotional Support

Support groups and patient advocacy organizations can provide valuable education and emotional support for individuals coping with chronic lung disease.

Coordinated Care

Successful management often requires a healthcare team that may include: